Biotech meets NIH to discuss poor disease markets

Nat Med. 2003 Jan;9(1):7. doi: 10.1038/nm0103-7a.
No abstract available

Publication types

  • News

MeSH terms

  • Biotechnology* / economics
  • Disease Management*
  • Disease Outbreaks
  • Drug Industry / economics
  • Humans
  • National Institutes of Health (U.S.)*
  • Research / economics
  • United States